AMY STEGER: Open Payments
NPI 1952728735 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 23 payments from 13 companies in 2025. Trend: 2023 $504 · 2024 $323 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $122 |
| Biogen, Inc. | 3 | $52 |
| Octapharma USA, Inc. | 2 | $48 |
| CooperSurgical, Inc. | 2 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $41 |
| PFIZER INC. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
Products named: Veozah, ZURZUVAE, FIBRYGA, Paragard T 380A, MYOSURE TISSUE REMOVAL DEVICE, Wegovy, COMIRNATY, MOUNJARO.
Industry payments across IA — which companies pay providers there.
